Published in Drug Week, November 23rd, 2001
"Antiplatelet drugs have been demonstrated to reduce the incidence of recurrent events in patients with symptomatic vascular disease," according to Lian Zhou and colleagues at the University of Nottingham's Centre for Vascular Research. "However, there is no experimental data indicating the effects of these agents when given together on platelets and leukocytes."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.